Form 4 for INGN Inogen Inc
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001193125-26-088586 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | A - Grant | $0.1792 | +29.7K | 94.6K | +46% | +$5,331 |
| DM | 2026-03-03 | 2026-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | F - Tax | $6.10 | -26.3K | 65.7K | -29% | -$160.5K |
| DM | 2026-03-03 | 2026-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | M - OptEx | $0.00 | +42.0K | 75.0K | +127% | $0 |
| DM | 2026-03-03 | 2026-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | M - OptEx | $0.00 | -42.0K | 25.0K | -63% | $0 |
| D | 2026-03-03 | 2026-02-27 | INGN | Bourque Michael J. | EVP, CFO, Treas | A - Grant | $0.00 | +39.0K | 39.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | A | A | 874 | $6.10 | 50,020 | D | — | — | (F1) Shares acquired through the Company's 2014 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-03-01 | F | D | 6,353 | $6.10 | 94,596 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. |
| 3 | Common | Common Stock | 2026-03-01 | M | A | 17,007 | $0.00 | 100,949 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-01 | F | D | 10,615 | $6.10 | 83,942 | D | — | — | (F4) The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026. |
| 5 | Common | Common Stock | 2026-03-01 | M | A | 25,000 | $0.00 | 75,020 | D | — | — | |
| 6 | Common | Common Stock | 2026-03-01 | F | D | 9,338 | $6.10 | 65,682 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. |
| 7 | Common | Common Stock | 2026-03-01 | A | A | 28,875 | $0.00 | 94,557 | D | — | — | (F3) The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024. |
| 8 | Derivative | Restricted Stock Unit | 2026-03-01 | M | D | 17,007 | $0.00 | 34,013 | D | — · — to — | 17,007 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F8) 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-27 | A | A | 39,000 | $0.00 | 39,000 | D | — · — to — | 39,000 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F6) Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. |
| 10 | Derivative | Restricted Stock Unit | 2026-03-01 | M | D | 25,000 | $0.00 | 25,000 | D | — · — to — | 25,000 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F7) 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. |